Biological markers predictive of rheumatoid arthritis...

Details Biological markers predictive of rheumatoid arthritis... Biological markers predictive of rheumatoid arthritis...

G - Physics

01

N

G01N 33/564 (2006.01)

Patent

CA 2737379

The present invention relates to a soluble lymphotoxin (so1LT) and methods of using the so1LT as a biomarker in the treatment of autoimmune disease. More particularly, the present invention relates to soluble lymphotoxin alpha-beta (so1LT.alpha..beta.) and methods of using this so1LT.alpha..beta. as a biomarker in the treatment of rheumatoid arthritis (RA).

La présente invention concerne une lymphotoxine soluble (solLT) et des procédés utilisant la solLT comme marqueur biologique dans le traitement dune maladie auto-immune. Plus particulièrement, la présente invention concerne une lymphotoxine alpha-bêta soluble (solLTaß) et des procédés utilisant cette solLTaß comme marqueur biologique dans le traitement de la polyarthrite rhumatoïde (RA).

Affiliated with

Also associated with

Rating

Biological markers predictive of rheumatoid arthritis... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biological markers predictive of rheumatoid arthritis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biological markers predictive of rheumatoid arthritis... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1786608